A question worth asking
Can a pharmacy make sermorelin lawfully?
Compounding means a pharmacy makes or mixes a medicine for a patient. To check an offer, start with the full ingredient name and the pharmacy’s name.
When a pharmacy may make it
A pharmacy with a state license may have a route to prepare sermorelin acetate for a person holding a valid prescription, as of September 28, 2026.
Here, acetate identifies the version of sermorelin used in the former approved medicine. It describes the ingredient, not whether it comes as a shot.
That prescription must be in your name. The pharmacy must also meet federal ingredient and pharmacy rules, plus the rules of the states involved.
Approval of the finished medicine
Before a product can be approved, it undergoes review at the Food and Drug Administration (FDA) for the particular use proposed.
A compounded preparation does not become FDA-approved through that route.
Which ingredient checks matter?
Under the federal rules reviewed on September 28, 2026, a maker must have its details recorded with the FDA to supply the raw ingredient.
It must come with a valid written report of test results and meet any official ingredient standards that apply.
The possible legal route described here is for sermorelin acetate. It does not cover every version of sermorelin.
This answer comes from the general federal rules. The research found no FDA statement naming sermorelin as allowed under these patient-by-patient pharmacy rules.
What else needs checking?
State pharmacy rules can add limits, so the federal route alone is not a complete answer.
Ask the pharmacist to confirm the ingredient checks and explain which state rules allow them to make and send your medicine. Keep that answer in writing.
For an answer about a particular offer, take the pharmacy’s name and its explanation to your state board of pharmacy, which oversees pharmacy licenses.
Space for your answers
Write for your own use. Keep a copy before leaving this page.
Ask for the full name rather than a general peptide label.
Who has answered, and what remains unclear?